These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1688319)

  • 1. New strategies in the search for anxiolytics.
    File SE
    Drug Des Deliv; 1990 Mar; 5(3):195-201. PubMed ID: 1688319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
    Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
    Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects of the search for novel anxiolytics].
    Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(5):4-17. PubMed ID: 12596506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats.
    Koss WA; Gehlert DR; Shekhar A
    Horm Behav; 2004 Aug; 46(2):158-64. PubMed ID: 15256305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
    Borsini F; Podhorna J; Marazziti D
    Psychopharmacology (Berl); 2002 Sep; 163(2):121-41. PubMed ID: 12202959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validation of animal tests of anxiety--pharmacological implications.
    File SE
    Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarylacetylene piperidinyl amides as novel anxiolytics.
    Kordik CP; Luo C; Gutherman M; Vaidya AH; Rosenthal DI; Crooke JJ; McKenney SL; Plata-Salaman CR; Reitz AB
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3065-7. PubMed ID: 16580201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of anxiolytics and anxiogenics on evaluation of learning and memory in an elevated plus-maze test in mice.
    Miyazaki S; Imaizumi M; Machida H
    Methods Find Exp Clin Pharmacol; 1995 Mar; 17(2):121-7. PubMed ID: 7674699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats.
    Silvestre JS; Nadal R; Pallarés M; Ferré N
    Depress Anxiety; 1997; 5(1):29-33. PubMed ID: 9250438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.
    Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS
    Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats.
    Isogawa K; Fujiki M; Akiyoshi J; Tsutsumi T; Kodama K; Matsushita H; Tanaka Y; Kobayashi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):664-8. PubMed ID: 15905012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, computational and biological evaluation of new anxiolytics.
    Geronikaki A; Babaev E; Dearden J; Dehaen W; Filimonov D; Galaeva I; Krajneva V; Lagunin A; Macaev F; Molodavkin G; Poroikov V; Pogrebnoi S; Saloutin V; Stepanchikova A; Stingaci E; Tkach N; Vlad L; Voronina T
    Bioorg Med Chem; 2004 Dec; 12(24):6559-68. PubMed ID: 15556772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.